Back
Stoke Therapeutics Vs. Actinium Pharmaceuticals Industry Stock Comparison
Buy
72
STOK
Stoke Therapeutics
Last Price:
15.37
Seasonality Move:
-14.01%
Buy
53
ATNM
Actinium Pharmaceuticals
Last Price:
8.87
Seasonality Move:
-7.76%
Buy
72
Stoke Therapeutics (STOK)
is a Buy
Is Stoke Therapeutics a Buy, Sell or Hold?
- The current Stoke Therapeutics [STOK] share price is $16.10. The Score for STOK is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- STOK is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Actinium Pharmaceuticals (ATNM)
is a Buy
Is Actinium Pharmaceuticals a Buy, Sell or Hold?
- The current Actinium Pharmaceuticals [ATNM] share price is $9.69. The Score for ATNM is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- ATNM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
STOK Stock Price Chart
What is Stoke Therapeutics's stock price today?
-
The Stoke Therapeutics share price today is $16.10
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STOK is experiencing buying pressure, which is a positive indicator for future bullish movement.
ATNM Stock Price Chart
What is Actinium Pharmaceuticals's stock price today?
-
The Actinium Pharmaceuticals share price today is $9.69
The current trend is moderately bearish and ATNM is experiencing slight selling pressure.
STOK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.86 | Buy |
| Relative Strength Index (14 RSI): | 74.54 | Buy |
| Chaikin Money Flow: | 969548 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.09 - 13.37) | Buy |
| Bollinger Bands (100): | (4.88 - 11.78) | Buy |
ATNM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.51 | Buy |
| Relative Strength Index (14 RSI): | 64.31 | Buy |
| Chaikin Money Flow: | -46934 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.11 - 9.33) | Buy |
| Bollinger Bands (100): | (5.55 - 8.67) | Buy |
STOK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.25 | Buy |
| 20-day SMA: | 12.33 | Buy |
| 50-day SMA: | 11.1 | Buy |
| 200-day SMA: | 6.47 | Buy |
| 8-day EMA: | 13.72 | Buy |
| 20-day EMA: | 12.7 | Buy |
| 50-day EMA: | 11.15 | Buy |
| 200-day EMA: | 8.34 | Buy |
ATNM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.43 | Buy |
| 20-day SMA: | 8.49 | Buy |
| 50-day SMA: | 8.23 | Buy |
| 200-day SMA: | 6.38 | Buy |
| 8-day EMA: | 9.45 | Buy |
| 20-day EMA: | 8.87 | Buy |
| 50-day EMA: | 8.2 | Buy |
| 200-day EMA: | 7.15 | Buy |
Stoke Therapeutics Earnings Growth & STOK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $0.35 per share.
Actinium Pharmaceuticals Earnings Growth & ATNM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.46 per share, an increase this year of $0.45 per share, and an increase next year of $1.05 per share.
Stoke Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Actinium Pharmaceuticals Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||